Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-25
2005-01-25
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C514S396000, C514S398000, C514S352000, C540S490000, C544S269000, C544S323000, C546S122000, C546S123000, C546S312000, C548S307400
Reexamination Certificate
active
06846833
ABSTRACT:
Compounds of formula (1):wherein:G represents an optionally substituted phenyl or optionally substituted heterocycle, G1and G2being N or C,T1represents —CH2—CH2—, —CH═CH— or ═CH—CH2—, and T2is a bond, or T1represents —CH2— or ═CH— and T2is —CH2—, ═CH—,R5represents —(CH2)m—COOR6,R6and R6′represent hydrogen, alkyl, optionally substituted aryl or optionally substituted arylalkyl,A represents —CO—, —CH2—, ═CH— or —CH═ and W represents —CH—, ═C— or —C═, or A represents —CO— or —CH2— and W represents N,X represents —CO—X1—, —CO—NR6—X1—, —NR6—CO—X1—, —O—X1—, —SO2—NR6—X1— or —S(O)n—X1—,Y represents —Y1—, —Y2—Y1— or —Y1—Y2—Y1—, Y1being an alkylene, alkenylene or alkynylene, and Y2being an arylene, heteroarylene, cycloalkylene or heterocycloalkylene,Z represents —Z1—, —Z10—NR6—, and —Z10—NR6—CO—, Z1being a heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, fused arylheteroaryl, fused arylheterocycloalkyl, fused heteroarylheterocycloalkyl, fused heterocycloalkylheteroaryl or fused heteroarylheteroaryl, each of which is optionally substituted, or a group,Z2—NR6or Z2—NR6—CO, Z2being a group Z1, alkyl or heteroalkyl, andZ10represents Z1or an alkyl,its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base,and medicinal products containing the same which are useful as vitronectin receptor antagonists.
REFERENCES:
patent: 6239138 (2001-05-01), Ku
patent: 6403578 (2002-06-01), Bondinell et al.
patent: 2806082 (2001-09-01), None
patent: WO 9600730 (1996-01-01), None
patent: WO 9606087 (1996-02-01), None
patent: WO 9814192 (1998-04-01), None
patent: WO 9830542 (1998-07-01), None
patent: WO 9905107 (1999-02-01), None
patent: WO 9915508 (1999-04-01), None
Atassi Ghanem
Casara Patrick
Perron-Sierra Françoise
Saint-Dizier Dominique
Tucker Gordon
Les Laboratories Servier
Seaman D. Margaret
The Firm of Hueschen and Sage
LandOfFree
Vitronectin receptor antagonist bicyclic compounds,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitronectin receptor antagonist bicyclic compounds,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonist bicyclic compounds,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3396359